Purpose To investigate 1-year outcomes of intravitreal aflibercept for polypoidal choroidal
vasculopathy (PCV). Design Retrospective, multicenter, consecutive case series …

Purpose To investigate changes in subfoveal choroidal thickness after intravitreal aflibercept
injections (IAIs) for neovascular age-related macular degeneration (AMD) at 12 months …

Purpose: To compare the 1-year results of initial or deferred photodynamic therapy (PDT)
combined with intravitreal ranibizumab (IVR) for eyes with polypoidal choroidal …

Purpose To investigate changes in choroidal thickness after aflibercept therapy for
neovascular age-related macular degeneration (AMD). Design Retrospective, consecutive …

Purpose: To clarify the efficacy of switching to intravitreal aflibercept injection to treat
polypoidal choroidal vasculopathy refractory to ranibizumab. Methods: In this retrospective …

It is clarified for the first time that the effect of the mode coupling on the bandwidth
characteristic is very small in the graded-index polymer optical fiber (GI POF) compared with …

We conducted a genome-wide association study (GWAS) on the outcome of anti-VEGF
treatment for exudative age-related macular degeneration (AMD) in a prospective cohort …

To report a case complicated with a retinal pigment epithelium (RPE) tear after intravitreal
aflibercept injection. A 78-year-old man had deteriorated visual acuity in his left eye …

Background/aims To investigate short-term outcomes of intravitreal aflibercept injections
(IAIs) for polypoidal choroidal vasculopathy (PCV). Methods 91 eyes of 88 consecutive …

Background To clarify the efficacy of combined therapy with intravitreal ranibizumab
injections and photodynamic therapy (PDT) in patients with symptomatic polypoidal …